Insider Buying: ECO Animal Health Group (LON:EAH) Insider Acquires £19,887.94 in Stock

ECO Animal Health Group plc (LON:EAH) insider David Hallas acquired 22,346 shares of ECO Animal Health Group stock in a transaction that occurred on Thursday, July 16th. The stock was purchased at an average cost of GBX 89 per share, for a total transaction of £19,887.94.

ECO Animal Health Group Price Performance

EAH opened at GBX 87.20 on Friday. The business has a fifty day moving average of GBX 92.39 and a 200 day moving average of GBX 98.48. ECO Animal Health Group plc has a 52-week low of GBX 72 and a 52-week high of GBX 116.90. The stock has a market cap of £58.50 million, a P/E ratio of 19.86 and a beta of 0.00. The company has a quick ratio of 2.14, a current ratio of 3.42 and a debt-to-equity ratio of 5.66.

ECO Animal Health Group (LON:EAH) last issued its quarterly earnings results on Wednesday, July 15th. The company reported GBX 3.26 earnings per share (EPS) for the quarter. ECO Animal Health Group had a return on equity of 2.55% and a net margin of 2.50%.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.